A new approach for the treatment of bacterial vaginosis: Use of polyhexamethylene biguanide. A prospective, randomized study

European Review for Medical and Pharmacological Sciences

Volumn 7, Issue 5, 2003, Pages 127-130

  Gerli, S ^a   Rossetti, D ^a   Di Renzo, G C ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Bacterial vaginosis; Clindamycin; Metronidazole; PHMB

Indexed keywords

AGENTS USED INTRAVAGINALLY; CLINDAMYCIN; METRONIDAZOLE; MONOGIN; POLY(HEXAMETHYLENEBIGUANIDE);

ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG SOLUTION; DRUG TOLERABILITY; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SINGLE DRUG DOSE; SUPERINFECTION; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; BIGUANIDES; CLINDAMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SUPERINFECTION; TIME FACTORS; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINOSIS, BACTERIAL;

EID: 2442673037     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Thomason JL, Gelbart SM, Anderson R J, et al. Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol 1990; 162: 155-160.
2. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. Bacterial vaginosis: a public health review. Br J Obstet Gynaecol 2001; 108: 439-450.
3. Lin L, Song J, Kimber N, et al. The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol 1999; 7: 169-174.
4. Sweet RL. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995; 20 (Suppl 2): S271-275.
5. Wilson JD, Ralph SG, Jackson F, Rutherford AJ. Infertility, preterm birth, and bacterial vaginosis. Lancet 1999; 354:511.
6. Liversedge NH, Turner A, Horner PJ, Keay SD, Jenkins JM, Hull MG. The influence of bacterial vaginosis on in-vitro fertilization and embryo implantation during assisted reproduction treatment. Hum Reprod 1999; 14: 2411-2415.
7. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003; 189: 139-147.
8. Penney GC. Preventing infective sequelae of abortion. Hum Reprod 1997; 12 (Suppl): 107-112.
9. Rose FL, Swain G. Bisdiguanides having antibacterial activity. J Chem Soc 1956; 4422-4425.
10. Facchinetti F, Piccinini F, Mordini B, Volpe A. Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term. J Matern Fetal Neonatal Med 2002; 11: 84-88.
11. Rosin M, Welk A, Kocher T, Majic-Todt A, Kramer A, Pitten FA. The effect of a polyhexamethylene biguanide mouth rinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque regrowth. J Clin Periodontol 2002; 29: 392-399.
12. Buck SL, Rosenthal RA, Schlech BA. Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature. CLAO J 2000; 26: 72-84.
13. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
14. Scandinavian Society of Vaginal Bacteriosis. Report of the first meeting of SSVB. Gothemburg, Sweden, 1995. Acta J Obstet Gynecol 1996, 163: 16-19.
15. Dhar J, Arya OP, Timmins DJ, et al. Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study. Genitourin Med 1994; 70: 121-123.
16. Ahmed-Jushuf IH, Shahmanesh M, Arya OP. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicentre, double blind, placebo controlled trial. B V Investigators Group. Genitourin Med 1995; 71: 254-256.
17. Livengood CH, Thomason JL, Hill GB. Bacterial vaginosis: treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 1990; 76: 118-123.
18. Gilbert P, Pemberton D, Wilkinson DE. Barrier properties of the gram-negative cell envelope towards high molecular weight polyhexamethylene biguanides. J Appl Bacteriol 1990; 69: 585-592.
19. Pelletier C, Bouley C, Cayuela C, Bouttier S, Bourlioux P, Bellon-Fontaine MN. Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains. Appl Environ Microbiol 1997; 63: 1725-1731.